We've found
2,621
archived clinical trials in
Urology
We've found
2,621
archived clinical trials in
Urology
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
Updated: 12/31/1969
Phase 2, Open-Label Extension Study to Assess Long-Term Safety and Tolerability of Enobosarm (GTx 024) in Postmenopausal Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Updated: 12/31/1969
A Phase IIa Single-Center, Open-Label Study Evaluating the Pharmacokinetics of Repeat Oral Doses of Gepotidacin (GSK2140944) in Adult Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Status: Enrolling
Updated: 12/31/1969
Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Updated: 12/31/1969
A Phase IIa Single-Center, Open-Label Study Evaluating the Pharmacokinetics of Repeat Oral Doses of Gepotidacin (GSK2140944) in Adult Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Connected Catheter (C2P) Study for Bladder Management
Updated: 12/31/1969
Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Incontinence Management System ICU Field Evaluation
Updated: 12/31/1969
Hill-Rom Incontinence Management System ICU Field Evaluation
Status: Enrolling
Updated: 12/31/1969
Incontinence Management System ICU Field Evaluation
Updated: 12/31/1969
Hill-Rom Incontinence Management System ICU Field Evaluation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
Updated: 12/31/1969
The Effect of Gentamicin Intravesical Installations on Decreasing Urinary Tract Infections in Patients With Neurogenic Bladder After Spinal Cord Injury: A Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
Updated: 12/31/1969
The Effect of Gentamicin Intravesical Installations on Decreasing Urinary Tract Infections in Patients With Neurogenic Bladder After Spinal Cord Injury: A Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs
Updated: 12/31/1969
Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs
Status: Enrolling
Updated: 12/31/1969
Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs
Updated: 12/31/1969
Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
eCoin Tibial Nerve Stimulation for OAB
Updated: 12/31/1969
Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
Updated: 12/31/1969
A Placebo-Controlled, Single-Blind, Single-Center Phase 1 Study in Normal Healthy Volunteers and Open-Label Multi-Center Study in Patients With Primary Hyperoxaluria to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of DCR-PHXC Solution for Injection (Subcutaneous Use)
Status: Enrolling
Updated: 12/31/1969
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
Updated: 12/31/1969
A Placebo-Controlled, Single-Blind, Single-Center Phase 1 Study in Normal Healthy Volunteers and Open-Label Multi-Center Study in Patients With Primary Hyperoxaluria to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of DCR-PHXC Solution for Injection (Subcutaneous Use)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
Updated: 12/31/1969
A Placebo-Controlled, Single-Blind, Single-Center Phase 1 Study in Normal Healthy Volunteers and Open-Label Multi-Center Study in Patients With Primary Hyperoxaluria to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of DCR-PHXC Solution for Injection (Subcutaneous Use)
Status: Enrolling
Updated: 12/31/1969
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
Updated: 12/31/1969
A Placebo-Controlled, Single-Blind, Single-Center Phase 1 Study in Normal Healthy Volunteers and Open-Label Multi-Center Study in Patients With Primary Hyperoxaluria to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of DCR-PHXC Solution for Injection (Subcutaneous Use)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Updated: 12/31/1969
Medical Therapy of Prostatic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Updated: 12/31/1969
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials